ARTICLE | Clinical News
Thromboreductin regulatory update
July 26, 2004 7:00 AM UTC
AOP said Thromboreductin anegrelide received marketing authorization in Austria, Poland, Slovenia, Slovakia, Latvia, Hungary, Lithuania and the Czech Republic to treat essential thrombocythemia. ...